Disease tolerance is the key to treating TB, say experts

A new study from McGill University suggests it is the body’s ability to “tolerate” rather than “resist” TB infection that stops symptoms of the disease developing.

Credit: Kateryna Kon/Shutterstock.com

The study, which was recently published in the journal Science Immunology, lends support to the idea that understanding “disease tolerance” is the key to developing strategies that mitigate the consequences of infection.

Historically, scientists’ perspective on host defence against infection has been that the body eradicates disease by eliminating pathogens.

However, pulmonary immunologist and professor of Medicine Dr Maziar Divangahi has been trying to understand why the vast majority of people infected with Mycobacterium tuberculosis (Mtb) tolerate the bacteria, without receiving any treatment.

This “latent tuberculosis” is a perfect example of disease tolerance, says Divangahi, and it exists within a whole quarter of the population worldwide.

Divangahi and team have now found that it is the body’s ability to tolerate the Mtb pathogen rather than fight it that prevents the infection from spreading.

More surprisingly, they also found that having excessive levels of T cells –  cells known to be key in fighting infection – could cause more harm than good.

We always thought that having more T cells would provide better protection against TB. Instead, we found that it could imbalance disease tolerance causing extensive tissue damage and ultimately killing the host.”

Dr Maziar Divangahi, Lead Author

The study found that a protein in mitochondria called cyclophilin D (CypD) serves as a key checkpoint for T cell activation and is essential for the control of T cell metabolism.

While scientists had previously considered T cells to be important in eliminating Mtb, Divangahi says this study showed that increasing T cell activation in mice by eliminating a metabolic checkpoint unexpectedly compromised host survival, without any impact on the growth of Mtb.

In contrast to conventional thinking, we show that T cells are essential for regulating the body’s tolerance to Mtb infection.”

Dr Nargis Khan, Co-Author

Given the widespread drug resistance of various Mtb strains and the lack of a vaccine or effective antibiotics, the need for alternative treatment approaches is urgent.  

“If we could understand the mechanisms of ‘natural immunity’ that controls TB in 90-95 per cent of infected individuals, we will able to design a novel therapy or vaccine to substantially reduce the world-wide burden of this ancient disease,” says Divangahi.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 19). Disease tolerance is the key to treating TB, say experts. News-Medical. Retrieved on December 02, 2022 from https://www.news-medical.net/news/20180514/Disease-tolerance-is-the-key-to-treating-TB-say-experts.aspx.

  • MLA

    Robertson, Sally. "Disease tolerance is the key to treating TB, say experts". News-Medical. 02 December 2022. <https://www.news-medical.net/news/20180514/Disease-tolerance-is-the-key-to-treating-TB-say-experts.aspx>.

  • Chicago

    Robertson, Sally. "Disease tolerance is the key to treating TB, say experts". News-Medical. https://www.news-medical.net/news/20180514/Disease-tolerance-is-the-key-to-treating-TB-say-experts.aspx. (accessed December 02, 2022).

  • Harvard

    Robertson, Sally. 2019. Disease tolerance is the key to treating TB, say experts. News-Medical, viewed 02 December 2022, https://www.news-medical.net/news/20180514/Disease-tolerance-is-the-key-to-treating-TB-say-experts.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Multivalent mRNA-based vaccine may serve as a preventative measure against future flu pandemics